Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The importance of staying within range: associations between tacrolimus intrapatient variability and kidney transplant outcomes.

Frontiers in immunology·2026
Same author

Differences in Mortality by Donor Sex and Age in a Multinational Cohort of Liver Transplant Recipients.

Transplantation direct·2026
Same author

Differences in mortality by donor sex and age in heart transplantation: An individual patient data meta-analysis.

JHLT open·2026
Same author

Corrigendum: Hidden in Plain Sight: High Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Long-term compromised immune regulation after rituximab induction in blood group incompatible (ABOi) living-donor renal transplantation - 5 year results of a prospective pilot study.

Frontiers in immunology·2025
Same author

Hidden in Plain Sight: Low Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality.

Transplant international : official journal of the European Society for Organ Transplantation·2025

Related Experiment Video

Updated: Jun 22, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Lymphomas after solid organ transplantation: a collaborative transplant study report.

Gerhard Opelz1, Bernd Döhler

  • 1Department of Transplantation Immunology, University of Heidelberg, Heidelberg, Germany. gerhard.opelz@med.uni-heidelberg.de

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|February 21, 2004
PubMed
Summary

Organ transplant recipients face a significantly higher risk of developing malignant lymphomas, particularly after the first year. Certain immunosuppressive drugs and therapies increase this risk, leading to poor patient outcomes.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Related Experiment Videos

Last Updated: Jun 22, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Area of Science:

  • Transplant medicine
  • Oncology
  • Immunology

Background:

  • Malignant lymphomas are a serious complication in organ transplant recipients.
  • Understanding the incidence, risk factors, and impact of these lymphomas is crucial for patient management.

Purpose of the Study:

  • To analyze the incidence, risk, and impact of malignant lymphomas in a large cohort of organ transplant recipients.
  • To identify specific transplant types, immunosuppressive agents, and therapies associated with increased lymphoma risk.
  • To assess patient outcomes and mortality associated with post-transplant lymphoma.

Main Methods:

  • Analysis of the Collaborative Transplant Study database, including approximately 200,000 organ transplant recipients.
  • Comparison of lymphoma risk in transplant recipients versus a matched non-transplanted population.
  • Evaluation of risk factors including transplant type, immunosuppressive drugs (cyclosporine, azathioprine/steroids, FK506), and induction/antirejection therapies (OKT3, ATG, anti-IL2 receptor antibodies).

Main Results:

  • Renal transplant recipients had an 11.8-fold higher risk of lymphoma compared to the general population.
  • Heart-lung transplants exhibited the highest relative risk (RR 239.5).
  • FK506 treatment approximately doubled lymphoma risk; OKT3 and ATG (induction and antirejection) also increased risk.
  • Lymphomas were predominantly diagnosed after the first post-transplant year.
  • First-year mortality for renal and heart transplant patients with lymphoma was high (approx. 40% and 50%) with no recent improvement.
  • Lymphoma localization near the transplant impacted patient prognosis.

Conclusions:

  • Organ transplant recipients have a persistently elevated risk of malignant lymphoma over time.
  • Specific immunosuppressive strategies significantly contribute to the increased risk of post-transplant lymphoma.
  • Outcomes for patients with post-transplant lymphoma remain poor, highlighting the need for improved prevention and treatment strategies.